Rubio, Esteban
Moreno, Mª. José
Gallego, Adela
Castrejón, Isabel
Cobo, Amelia
Moyano, Sebastián
Comellas, Marta https://orcid.org/0000-0002-5275-9882
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 3 April 2025
Accepted: 27 June 2025
First Online: 17 July 2025
Declarations
:
: Esteban Rubio reports honoraria from Lilly and Galapagos outside the submitted work. Mª José Moreno declares no conflicts of interest. Adela Gallego and Isabel Castrejón reports honoraria from Lilly outside the submitted work. Amelia Cobo and Sebastián Moyano are employees of Lilly. Marta Comellas works for an independent scientific consultancy (Outcomes’10) that has received honoraria for the study coordination and writing the current manuscript.
: This study did not require approval from an ethics committee, as it did not involve patients or animals. The study solely reflects the perspectives of healthcare professionals who were invited to participate. All participants gave their informed consent to take part in the study. No identifying personal information is included in the manuscript, and all participants consented to the publication of their opinions. The study was conducted in accordance with the principles outlined in the Declaration of Helsinki (1964, and its later amendments). Given the nature of this research, no further ethical approval or institutional review board (IRB) approval was necessary.